Showing 7961-7970 of 20878 results for "".
The International Diabetes Federation's Global Campaign
https://reachmd.com/programs/diabetes-discourse/the-international-diabetes-federations-global-campaign/4942/World Diabetes Day marks the annual global awareness campaign for diabetes by the International Diabetes Federation. The campaign’s theme of "diabetes education and prevention" is scheduled for five years. How will the IDF implement this broad campaign for both the health care professionals and peopAdjustment to Diabetes Diagnosis / New Technology
https://reachmd.com/programs/clinicians-roundtable/adjustment-to-diabetes-diagnosis-new-technology/328/Dr. Laffel, chief of the Pediatric and Adolescent Section at Joslin Clinic and an Investigator in the section on Genetics and Epidemiology at Joslin Diabetes Center as well as an Associate Professor of Pediatrics at Harvard Medical School discusses adjustment to the diagnosis of Type 1 diabetes. ShThe Certified Diabetes Educator: A Key Role in the Diabetes Team
https://reachmd.com/programs/diabetes-discourse/the-certified-diabetes-educator-a-key-role-in-the-diabetes-team/5640/Diabetes educators focus on helping patients living with diabetes and related conditions achieve behavior change goals and lead to better clinical outcomes and improved health status. How has the role of the certified diabetes educator changed in the management of diabetes? Join host Dr. Steven EdelOral Agents for Diabetes: What to Choose and When
https://reachmd.com/programs/diabetes-discourse/oral-agents-for-diabetes-what-to-choose-and-when/5340/We now have many choices of oral agents in the treatment of type 2 diabetes patients. But choosing the type and where they fit in the treatment algorithm can be a challenge. Join host Dr. Steven Edelman and his guest, director of the Harold Schnitzer Diabetes Health Center, Dr. Andrew Ahmann, as theThe Importance of Diabetes Education for Patients and Providers
https://reachmd.com/programs/diabetes-discourse/the-importance-of-diabetes-education-for-patients-and-providers/4846/The results of the landmark Diabetes Control and Complications Trial proved that intensive management of diabetes can significantly improve diabetes outcomes. The education of both the healthcare professional and patient is a key component in the successful management of diabetes. Join host Dr. StevType1 Diabetes Cure Research & Autoimmune Diseases
https://reachmd.com/programs/clinicians-roundtable/type1-diabetes-cure-research-autoimmune-diseases/1772/Dr. Denise L. Faustman, Associate Professor of Medicine at Harvard Medical School and Director of the Immunobiology Laboratories at the Massachusetts General Hospital discusses how her Type 1 diabetes cure research may be applicable to other autoimmune diseases such as lupus.Digital Innovation in Diabetes Prevention for Older Adults
https://reachmd.com/programs/diabetes-discourse/digital-diabetes-prevention/57028/Can older adults successfully engage with telehealth, wearable technology, and digital health tools to prevent type 2 diabetes? In this conversation with Dr. Steve Jackson, Dr. Emily Johnston and Dr. Souptik Barua discuss emerging insights on how these strategies could improve accessibility and engaRethinking Diabetes Care: Key Data from Incorporating Lifestyle Modifications
https://reachmd.com/programs/medical-industry-feature/rethinking-diabetes-care-key-data-from-incorporating-lifestyle-modifications/14289/What role do lifestyle modifications have in managing obesity and type 2 diabetes? Find out.Balancing Blood Sugar: The Role of Yoga in Diabetes Management
https://reachmd.com/programs/what-your-patients-are-talking-about/tbd/15490/Tune in to find out how yoga can help lower blood sugar levels in patients with type 2 diabetes.Obesity, Diabetes and the Metabolic Syndrome
https://reachmd.com/programs/lipid-luminations/obesity-diabetes-and-the-metabolic-syndrome/6706/Host Dr. Alan S. Brown is joined by Kevin C. Maki, PhD, FNLA, Chief Science Officer of Biofortis Clinical Research. Dr. Maki will review obesity, metabolic syndrome and type 2 diabetes mellitus as they are all insulin resistant states and are often characterized by atherogenic dyslipidemia or the